Effect of Methylprednisolone on Ischemic Brain Edema After Temporary Occlusion of the Middle Cerebral Artery in Rats

P Kozler1, V Herynek, J Pokorný

  • 1Institute of Physiology, First Faculty of Medicine, Charles University, Czech Republic. jaroslav.pokorny@lf1.cuni.cz.

Physiological Research
|December 2, 2025
PubMed

Insights

Methylprednisolone (MP) effectively reduced ischemic brain edema following temporary middle cerebral artery occlusion. This steroid treatment mitigated brain swelling, likely due to its antioxidant properties.

Area of Science:

  • Neuroscience
  • Pharmacology
  • Medical Imaging

Background:

  • Ischemic stroke leads to brain edema, a critical factor in patient outcomes.
  • Understanding the mechanisms and effective treatments for ischemic brain edema is crucial.

Purpose of the Study:

  • To investigate the therapeutic effect of Methylprednisolone (MP) on ischemic brain edema.
  • To evaluate MP's impact on brain water content and diffusion parameters post-stroke.

Main Methods:

  • Temporary middle cerebral artery occlusion (MCAo) model in animals.
  • Assessment of brain water content (BWC) via dry/wet weight measurements.
  • Magnetic Resonance Imaging (MRI) including T2-weighted imaging, T2 relaxation times, and apparent diffusion coefficient (ADC) analysis.

Main Results:

  • MCAo induced significant increases in BWC and ADC, confirming ischemic edema.
  • MP administration post-MCAo significantly reduced brain swelling compared to the MCAo group.
  • No significant difference in BWC or ADC was observed between the Methylprednisolone-treated group and control animals.

Conclusions:

  • Methylprednisolone demonstrates a significant therapeutic effect in reducing ischemic brain edema.
  • MP's antioxidant capacity is proposed as the primary mechanism for mitigating brain swelling.
  • MP may influence brain water movement and cellular metabolism to reduce edema post-stroke.